A 12-Week Home-Based Electrical Stimulation Program for Strength in Adults With Knee Osteoarthritis

Sponsor
Cionic, Inc. (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05765435
Collaborator
(none)
45
1
3
6
7.4

Study Details

Study Description

Brief Summary

The purpose of this research is to investigate if a 12-week program of stimulation assisted activities can combat disuse atrophy for individuals diagnosed with knee osteoarthritis (KOA). This study will use a home-based medical device to administer electrical stimulation and measure its effect on outcomes that include quadriceps strength, perceived functional capacity, pain, and walking performance. It was hypothesized that stimulation assisted activities will show larger muscle mass and strength improvements; improved gait kinematics, pain and perceived function; and a high compliance to the assigned program compared to no stimulation.

Condition or Disease Intervention/Treatment Phase
  • Other: 12-week exercise and walking program
  • Device: NMES
  • Device: FES
N/A

Detailed Description

The study aims to evaluate the Cionic Neural Sleeve for subjects diagnosed with KOA. All participants will be assigned a Cionic Neural Sleeve to wear on the most impacted leg and be prescribed a home-based exercise and walking program. Participants will be randomly assigned into three groups: (a) control; (b) neuromuscular electrical stimulation (NMES); (c) NMES and functional electrical stimulation (FES). The control group will not receive stimulation for the exercise and walking program, whereas participants in the NMES group will receive stimulation during exercises, and participants in the NMES and FES group will receive stimulation during exercises and walking. The primary outcome measures include quadriceps strength and perceived pain. Exploratory outcome measures include adherence to the program, thigh muscle volume, functional ability of the lower limb, walking performance, perceived functional capacity, and perceived quality of life.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effects of an Electrical Stimulation Program on Strength, Functional Capacity, Pain, and Gait in Individuals With Knee Osteoarthritis
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Control

Device: Cionic Neural Sleeve NS-100. Participants will wear the device during the 12-week exercise and walking program. There will be no stimulation.

Other: 12-week exercise and walking program
The exercise program requires isometric quadriceps contractions in a supine position with a rolled-up towel placed behind the knee. The exercise program will be performed by participants 5 days per week for 12 weeks. The walking program will be performed 3 days per week for 12 weeks. Participants will walk for 10 minutes and then gradually increase walking time to 30 minutes by the end of the study. Participants will wear the device during the exercise and walking program, which may range from 1 minute to 35 minutes per day.

Experimental: NMES

Device: Cionic Neural Sleeve NS-100. Participants will wear the device during the 12-week exercise and walking program and receive stimulation assistance during the exercise sessions.

Other: 12-week exercise and walking program
The exercise program requires isometric quadriceps contractions in a supine position with a rolled-up towel placed behind the knee. The exercise program will be performed by participants 5 days per week for 12 weeks. The walking program will be performed 3 days per week for 12 weeks. Participants will walk for 10 minutes and then gradually increase walking time to 30 minutes by the end of the study. Participants will wear the device during the exercise and walking program, which may range from 1 minute to 35 minutes per day.

Device: NMES
Sleeve applies neuromuscular stimulation during exercises to help contract appropriate muscles at appropriate times.
Other Names:
  • External functional neuromuscular stimulator
  • Experimental: NMES and FES

    Device: Cionic Neural Sleeve NS-100. Participants will wear the device during the 12-week exercise and walking program and receive stimulation assistance during the exercise and walking sessions.

    Other: 12-week exercise and walking program
    The exercise program requires isometric quadriceps contractions in a supine position with a rolled-up towel placed behind the knee. The exercise program will be performed by participants 5 days per week for 12 weeks. The walking program will be performed 3 days per week for 12 weeks. Participants will walk for 10 minutes and then gradually increase walking time to 30 minutes by the end of the study. Participants will wear the device during the exercise and walking program, which may range from 1 minute to 35 minutes per day.

    Device: NMES
    Sleeve applies neuromuscular stimulation during exercises to help contract appropriate muscles at appropriate times.
    Other Names:
  • External functional neuromuscular stimulator
  • Device: FES
    Sleeve applies functional electrical stimulation as patients walk to help contract appropriate muscles at appropriate times.
    Other Names:
  • External functional neuromuscular stimulator
  • Outcome Measures

    Primary Outcome Measures

    1. Change in Maximal Voluntary Isometric Contraction of the Quadriceps Using a Dynamometer [Baseline, 6 weeks, 12 weeks]

      Strength assessment of the quadriceps muscles using a handheld dynamometer, measured in Newtons.

    2. Change in Perceived Pain Scores Assessed by the Western Ontario/McMaster Universities Osteoarthritis Index (WOMAC) [Baseline, 6 weeks, 12 weeks]

      WOMAC pain questionnaire to measure perceived pain, measured by score. Scores on the WOMAC pain subscale range from 0 to 20, with high scores indicative of worse pain.

    Other Outcome Measures

    1. Change in Perceived Functional Capacity [Baseline, 6 weeks, 12 weeks]

      WOMAC physical function (WOMAC-PF) questionnaire to measure perceived functional capacity, measured by score. Scores on the WOMAC-PF subscale range from 0 to 68, with high scores indicative of worse functional limitations.

    2. Change in Walking Performance [Baseline, 6 weeks, 12 weeks]

      Measured by gait speed via the 10-meter walk test (meters per second) and walking endurance via the 6-minute walk test (meters).

    3. Adherence to the Program [Daily]

      Measured by the usage log of the device or exercise diary/calendar, measured in minutes.

    4. Change in Thigh Muscle Volume [Baseline, 6 weeks, 12 weeks]

      Measured by thigh circumference using a tape measure and prediction model to estimate muscle volume, measured in cubic centimeters.

    5. Change in Functional Ability of the Lower Limb [Baseline, 6 weeks, 12 weeks]

      Measured by the Five Times Sit to Stand Test, measured in seconds.

    6. Change in Perceived Quality of Life [Baseline, 6 weeks, 12 weeks]

      Short Form 36 questionnaire to measure quality of life, measured by score. Score ranges from 0 to 100, with 0 representing extreme interference, and 100 representing no interference in quality of life.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    22 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Persons with knee osteoarthritis between the ages of 22 and 75

    2. Ability to walk a duration of 30 minutes per walking session (with or without an assistive device), for three days per week

    3. Able to tolerate the device for up to 1 hour per lab session

    4. No recent change in medication or exacerbation of symptoms over the last 60 days

    5. Radiographic KOA Kellgren and Lawrence grade 2 or 3 or physician diagnosed mild or moderate KOA if radiographic imaging is not available

    6. No hyaluronic acid or cortisone injection into knees in previous 12 months

    Exclusion Criteria:
    1. Lower motor neuron disease or injury (e.g. peripheral neuropathy) that may impair response to stimulation

    2. Absent sensation in the impacted or more impacted leg

    3. Inadequate response to stimulation, as defined as inability to achieve muscle contraction or tolerate stimulation

    4. Inability to ambulate with the sleeve in place of an ankle foot orthosis (AFO)/knee ankle foot orthosis (KAFO) if utilized

    5. Use of FES devices in the past year

    6. Demand-type cardiac pacemaker or defibrillator

    7. Malignant tumor in the impacted or more impacted leg

    8. Existing thrombosis in the impacted or more impacted leg

    9. Fracture or dislocation in the impacted or more impacted leg that could be adversely affected by motion from stimulation

    10. History of knee surgery

    11. History of other types of arthritis

    12. History of neurological disease

    13. History of seizures or diagnosed with epilepsy/seizures

    14. Current pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cionic, Inc. San Francisco California United States 94133

    Sponsors and Collaborators

    • Cionic, Inc.

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Rebecca Webster, Director of Clinical Operations and Research, Cionic, Inc.
    ClinicalTrials.gov Identifier:
    NCT05765435
    Other Study ID Numbers:
    • CIONIC-05-001
    First Posted:
    Mar 13, 2023
    Last Update Posted:
    Mar 13, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 13, 2023